Multiple Sclerosis is a long-term illness where the body’s immune system attacks and damages the protective covering, called myelin, around the nerves in the central nervous system. People with relapsing MS will have repeated attacks, known as relapses, and we’re finding new ways to stop them.
People with MS can experience a variety of symptoms, including problems with vision, bladder control, arm or leg movement, sensation, or balance. Relapsing MS is characterized by attacks, also called relapses, meaning new or worsening of symptoms lasting for at least 24 hours, before full or partial recovery.
If you’ve been diagnosed with relapsing Multiple Sclerosis, you may qualify for this clinical research study. A study doctor will assess your eligibility for the study. You will have time to ask any questions that you may have.
The Bradenton Research Center
Since 1992, the Bradenton Research Center has completed over 150 clinical research studies. The diseases we’ve studied include Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Influenza, Migraines, Neuropathic Pain, Gout, Hypertension, Stroke, Type 2 Diabetes, Diabetic Neuropathy, Epilepsy, COVID-19, and many others. Patients enrolled in our studies are closely monitored by our research physicians and coordinators. All study-related care and medication is provided to our patients at no cost.
It is fulfilling to see the significant progress in the treatments of the diseases we’ve studied. Without clinical trials, we wouldn’t have any of the medicines that we take every single day. We’re currently engaged in more than a dozen studies. It’s through this research that we’re hopeful to find these better treatments and cures.
For more information, please call us at 941-708-0005. We rely on word of mouth referrals from much of our community. If you’ve enjoyed your experience with us, please tell your friends by sharing this on your social media networks and/or forwarding to their email address. Thank you in advance for your support.